Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection

Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection

Abstract Pulmonary hypertension (PH) complicates the treatment of interstitial lung disease (ILD) patients resulting in poor functional status and worse outcomes. Early recognition of PH in ILD is important for initiating therapy and considering lung transplantation. However, no standard exists rega...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Raj Parikh, Ippokratis Konstantinidis, David M. O'Sullivan, Harrison W. Farber
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	Wiley 2022-10-01
Σειρά:	Pulmonary Circulation
Θέματα:	idiopathic pulmonary fibrosis interstitial lung disease prostacyclin pulmonary hypertension treprostinil
Διαθέσιμο Online:	https://doi.org/10.1002/pul2.12141

Παρόμοια τεκμήρια

The PH‐ILD Detection tool: External validation and use in patients with ILD
ανά: Raj Parikh, κ.ά.
Έκδοση: (2023-07-01)

Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients
ανά: Julia McSweeney, κ.ά.
Έκδοση: (2023-04-01)

Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil
ανά: Aparna C. Swaminathan, κ.ά.
Έκδοση: (2024-11-01)

Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration
ανά: Jenna M. Faircloth, κ.ά.
Έκδοση: (2023-03-01)

Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration
ανά: Jenna M. Faircloth, κ.ά.
Έκδοση: (2023-08-01)

The Importance of Dose Escalation in the Treatment of Pulmonary Arterial Hypertension with Treprostinil
ανά: Piotr Kędzierski, κ.ά.
Έκδοση: (2025-01-01)

Inhaled therapies targeting prostacyclin pathway in pulmonary hypertension due to COPD: systematic review
ανά: Abdullah A. Alqarni, κ.ά.
Έκδοση: (2023-08-01)

Real‐world use of inhaled treprostinil for lung disease‐pulmonary hypertension: A protocol for patient evaluation and prescribing
ανά: Shelsey W. Johnson, κ.ά.
Έκδοση: (2022-07-01)

INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)
ανά: Nicholas S. Hill, κ.ά.
Έκδοση: (2022-07-01)

Evolution of pulmonary hypertension in interstitial lung disease: a journey through past, present, and future
ανά: Ahmad Arslan, κ.ά.
Έκδοση: (2024-01-01)

PAH-specific therapy for pulmonary hypertension and interstitial lung disease: A systemic review and meta-analysis
ανά: Ning Zhao, κ.ά.
Έκδοση: (2022-11-01)

Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia
ανά: Maria S. Nashatyreva, κ.ά.
Έκδοση: (2023-01-01)

Unexpected Acceleration in Treprostinil Delivery Administered by a Lenus Pro® Implantable Pump in Two Patients Treated for Pulmonary Arterial Hypertension
ανά: Garance Kopp, κ.ά.
Έκδοση: (2020-10-01)

Reasons for refusing parenteral therapy: a qualitative study of patients with pulmonary arterial hypertension
ανά: Kellie Morland, κ.ά.
Έκδοση: (2021-10-01)

Interstitial Lung Abnormality in Asian Population
ανά: Gong Yong Jin
Έκδοση: (2024-04-01)

The application of metabolomics toward idiopathic pulmonary fibrosis and potential metabolomic value of diverse samples in interstitial lung diseases
ανά: Mingtao Liu, κ.ά.
Έκδοση: (2023-09-01)

CLINICAL PROFILE OF INTERSTITIAL LUNG DISEASES CASES
ανά: Gagiya Ashok K, κ.ά.
Έκδοση: (2012-03-01)

Converging Pathways: A Review of Pulmonary Hypertension in Interstitial Lung Disease
ανά: Alexandra Lawrence, κ.ά.
Έκδοση: (2024-09-01)

Pulmonary Hypertension in Interstitial Lung Disease: Updates in Disease, Diagnosis, and Therapeutics
ανά: Zachary A. Haynes, κ.ά.
Έκδοση: (2023-10-01)

Prostacyclin receptor agonist selexipag in a patient with high-risk idiopathic pulmonary arterial hypertension: a case report
ανά: E. A. Rezukhina, κ.ά.
Έκδοση: (2021-09-01)

Interstitial lung diseases with progressive pulmonary fibrosis: pathogenetic features and approaches to therapy
ανά: N. A. Kuzubova, κ.ά.
Έκδοση: (2020-11-01)

Therapeutic Potential of Treprostinil Inhalation Powder for Patients with Pulmonary Arterial Hypertension: Evidence to Date
ανά: Cassady SJ, κ.ά.
Έκδοση: (2024-06-01)

Osteopontin as a Biomarker in Interstitial Lung Diseases
ανά: David Iturbe-Fernández, κ.ά.
Έκδοση: (2024-05-01)

Multidisciplinary discussion for diagnosis of interstitial lung disease in real life
ανά: Sabina Anna Guler, κ.ά.
Έκδοση: (2016-05-01)

Increased expiratory flows identify early interstitial lung disease
ανά: Sami Mohammed Alyami, κ.ά.
Έκδοση: (2023-01-01)

Role of Telomere Length in Survival of Patients with Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
ανά: Sofía Tesolato, κ.ά.
Έκδοση: (2023-12-01)

Digital quantification of p16-positive foci in fibrotic interstitial lung disease is associated with a phenotype of idiopathic pulmonary fibrosis with reduced survival
ανά: Jonathan Keow, κ.ά.
Έκδοση: (2022-06-01)

Evaluation of progressive pulmonary fibrosis in non-idiopathic pulmonary fibrosis-interstitial lung diseases: a cross-sectional study
ανά: Özlem Erçen Diken, κ.ά.
Έκδοση: (2024-08-01)

Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis
ανά: Lianghua Xiao, κ.ά.
Έκδοση: (2024-09-01)

Estimation of plasmic concentration of the brain natriuretic peptide in interstitial pulmonary diseases with pulmonary hypertension: clinical role
ανά: N A Mukhin, κ.ά.
Έκδοση: (2009-03-01)

Altered prostanoid production by fibroblasts cultured from the lungs of human subjects with idiopathic pulmonary fibrosis
ανά: Pierson Richard, κ.ά.
Έκδοση: (2002-02-01)

Abnormal platelet aggregation in pediatric pulmonary hypertension
ανά: Stephanie S. Handler, κ.ά.
Έκδοση: (2022-07-01)

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management
ανά: Justin M. Oldham, κ.ά.
Έκδοση: (2017-08-01)

Interstitial lung abnormalities in a large clinical lung cancer screening cohort: association with mortality and ILD diagnosis
ανά: Avignat S. Patel, κ.ά.
Έκδοση: (2023-02-01)

Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapy
ανά: Hardin EA, κ.ά.
Έκδοση: (2016-11-01)

Bibliometric analysis of the pirfenidone and nintedanib in interstitial lung diseases
ανά: Jia Liu, κ.ά.
Έκδοση: (2024-04-01)

A Case of Interstitial Lung Disease-Related Pulmonary Hypertension Successfully Treated with Inhaled Iloprost
ανά: Ji Hoon Jang, κ.ά.
Έκδοση: (2024-08-01)

An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J)
ανά: Kazuya Ichikado, κ.ά.
Έκδοση: (2023-06-01)

Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy
ανά: Donna Steinbacher, κ.ά.
Έκδοση: (2024-04-01)

Prostacyclin pathway vasodilators in patients with chronic thromboembolic pulmonary hypertension (CTEPH): A systemic review and meta‐analysis of randomized controlled trials
ανά: Weijun Li, κ.ά.
Έκδοση: (2024-10-01)